Selected article for: "abnormally high and acute response"

Author: Protti, Alessandro; Meessen, Jennifer; Bottazzi, Barbara; Garlanda, Cecilia; Milani, Angelo; Bacci, Monica; Mantovani, Alberto; Cecconi, Maurizio; Latini, Roberto; Caironi, Pietro
Title: Circulating pentraxin 3 in severe COVID‐19 or other pulmonary sepsis
  • Cord-id: wx99br10
  • Document date: 2021_3_13
  • ID: wx99br10
    Snippet: The long pentraxin 3 (PTX3), described initially as a microvascular inflammation marker, is an acute-phase protein released by several cell types in response to infection or tissue damage. It contributes to resistance to bacteria, fungi, viruses, and inflammation regulation (1). Circulating PTX3 was abnormally high (>2 ng/ml) in all 958 patients with severe sepsis or septic shock included in a pre-planned sub-study of the Albumin Italian Outcome Sepsis (ALBIOS) trial (2).
    Document: The long pentraxin 3 (PTX3), described initially as a microvascular inflammation marker, is an acute-phase protein released by several cell types in response to infection or tissue damage. It contributes to resistance to bacteria, fungi, viruses, and inflammation regulation (1). Circulating PTX3 was abnormally high (>2 ng/ml) in all 958 patients with severe sepsis or septic shock included in a pre-planned sub-study of the Albumin Italian Outcome Sepsis (ALBIOS) trial (2).

    Search related documents:
    Co phrase search for related documents
    • abnormally high and acute phase: 1
    • abnormally high and acute respiratory: 1, 2, 3, 4
    • abnormally high and acute respiratory distress syndrome: 1, 2, 3
    • abnormally high and acute severe: 1, 2
    • abnormally high and acute severe organ dysfunction: 1
    • abnormally high and liver disease: 1
    • acute organ dysfunction and liver disease: 1
    • acute organ dysfunction and logistic regression: 1, 2, 3
    • acute organ dysfunction and logistic regression analysis: 1, 2
    • acute phase and liver disease: 1, 2, 3, 4, 5, 6
    • acute phase and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute phase and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute phase protein and logistic regression: 1, 2
    • acute phase protein and logistic regression analysis: 1
    • acute respiratory and additional marker: 1, 2
    • acute respiratory and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and liver insufficiency: 1, 2, 3, 4
    • acute respiratory and local policy: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory and local regulation: 1, 2